The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes.
Bell
David S H
DS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis
D000319:Adrenergic beta-Antagonists